Glucagon receptor antagonists, preparation and therapeutic uses

Details for Australian Patent Application No. 2006342059 (hide)

Owner Eli Lilly and Company

Inventors Zhu, Guoxin; Conner, Scott Eugene; Tripp, Allie Edward; Chappell, Mark Donald; Hipskind, Philip Arthur

Agent Spruson & Ferguson

Pub. Number AU-B-2006342059

PCT Pub. Number WO2007/120284

Priority 60/739,692 23.11.05 US

Filing date 21 November 2006

Wipo publication date 25 October 2007

Acceptance publication date 10 May 2012

International Classifications

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/120284 Priority application(s): WO2007/120284

10 May 2012 Application Accepted

  Published as AU-B-2006342059

6 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006342086-Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics

2006342055-Metabolites of wortmannin analogs and methods of using the same